We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/3/2021 09:25 | When will people actually wake up.MMs are not making you sell you do it yourself.They offer a price and you click the mouse.They prey on weak holders or traders its how the market makes money. | cwebb07 | |
02/3/2021 09:15 | The share has been walked down from 1.50 just last week to 1.25 thats nearly 20%. It looks like someone wants in cheap and the mms are trying slowly to bring it down to fill that order. | glasswala | |
02/3/2021 09:12 | Threshold bypass or Personality Bypass as he is known to his friends.I will keep calling him threshold | cwebb07 | |
02/3/2021 08:42 | Nice to see the COVID one is in Phase II | dope007 | |
02/3/2021 08:21 | Thanks SFS ! | thresholdbypass | |
02/3/2021 08:18 | March presentation hxxps://www.4dpharma | swallowsflysouth | |
02/3/2021 08:16 | Ahead of @4dpharmaplc ’s #NASDAQ listing, CEO Duncan Peyton discusses how biotechs can benefit from the #SPAC route with @evaluatevantage | thefartingcommie | |
02/3/2021 08:11 | Tough on noobs Tough on the causes of noobs | the stigologist | |
02/3/2021 08:10 | These lockdown noob financial gurus thought they actually move stock prices with their hot takes! [Clown face] These Telegram groups are a riot | the stigologist | |
02/3/2021 07:59 | Your on filter Please get the Stigs balls out your mouth.Your sycophantic behaviour is sad to watch. | bluebear1 | |
02/3/2021 07:57 | I can't seem to get past you donny | thresholdbypass | |
02/3/2021 07:53 | This Stig character clearly has some mental health issues.I've finally put him on ignore.Vile failed fund manager (so he says).Must of been sacked. | bluebear1 | |
02/3/2021 07:53 | Never argue with a fool; onlookers may not be able to tell the difference. | zydecoco | |
02/3/2021 07:49 | You're the last person on earth that hasn't blocked stig | pharmaboy3 | |
02/3/2021 07:45 | Update....today stig doesn’t rate DDDD...tomorrow he’ll probably be pro DDDD...😂 | oakey1 | |
02/3/2021 07:35 | No loafofbread is clutching at straws Merck are running 1300 trials involving Keytruda no 1 trial by itself will move the needle for them Same clutching of straws which leads rampers/noobs to describe 4D's appointments yesterday as 'heavyweights' 😂 | the stigologist | |
02/3/2021 07:29 | Does that mean our keytruda data wont be any good? | solooiler | |
02/3/2021 01:03 | Well let's hope they use some of the billions they earn to appoint some heavyweights to the Board rather than the nonentities they announced today | the stigologist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions